{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:22:00Z","timestamp":1773220920024,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.094","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:28:27Z","timestamp":1233480507000},"page":"1811-1815","source":"Crossref","is-referenced-by-count":18,"title":["A single-dose combination therapy that both prevents and treats anthrax infection"],"prefix":"10.1016","volume":"27","author":[{"given":"Dennis M.","family":"Klinman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Tross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.01.094_bib1","first-page":"13","article-title":"Anthrax pathogenesis and host response","volume":"225","author":"Hanna","year":"1998","journal-title":"Curr Top Microbiol Immunol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.01.094_bib2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1201-1271","article-title":"Bioterrorism: a clear and present danger","volume":"7","author":"Lane","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2009.01.094_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/path.1700730219","article-title":"The pathogenesis of anthrax following the administration of spores by the respiratory route","volume":"73","author":"Ross","year":"1957","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.vaccine.2009.01.094_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","volume":"54","author":"Henderson","year":"1956","journal-title":"J Hyg"},{"key":"10.1016\/j.vaccine.2009.01.094_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/br.30.3.657-659.1966","article-title":"Industrial inhalation anthrax: discussion","volume":"30","author":"Glassman","year":"1966","journal-title":"Bateriol Rev"},{"key":"10.1016\/j.vaccine.2009.01.094_bib6","unstructured":"Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites\u2014United States, 2001\u20132002. MMWR Morb Mortal Wkly Rep 2002;51(September (35)):786\u20139."},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.01.094_bib7","article-title":"Conference report on public health and clinical guidelines for anthrax","volume":"14","author":"Stern","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.01.094_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/pds.1547","article-title":"Adverse events associated with prolonged antibiotic use","volume":"17","author":"Meropol","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.01.094_bib9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3201\/eid0810.020331","article-title":"Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, DC, 2001","volume":"8","author":"Jefferds","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.01.094_bib10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"June (22)","key":"10.1016\/j.vaccine.2009.01.094_bib11","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.261.22.3273","article-title":"How often is medication taken as prescribed? A novel assessment technique","volume":"261","author":"Cramer","year":"1989","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2009.01.094_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1749-6632.1991.tb27276.x","article-title":"Suggestions for integrating it into drug development","volume":"618","author":"Harter","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2009.01.094_bib13","series-title":"Vaccines","article-title":"Anthrax","author":"Friedlander","year":"1998"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2009.01.094_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00152686","article-title":"Recent advances in the development of an improved, human anthrax vaccine","volume":"4","author":"Ivins","year":"1988","journal-title":"Eur J Epidemiol"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2009.01.094_bib15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/JVI.36.2.566-574.1980","article-title":"A cloned polyoma DNA fragment representing the 5\u2032 half of the early gene region is oncogenic","volume":"36","author":"Chowdhury","year":"1980","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.01.094_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume":"1","author":"Little","year":"1999","journal-title":"Microb Infect"},{"issue":"June (Pt 6)","key":"10.1016\/j.vaccine.2009.01.094_bib17","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.01.094_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0882-4010(88)90015-0","article-title":"Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice","volume":"5","author":"Welkos","year":"1988","journal-title":"Microb Pathog"},{"issue":"December (5\u20136)","key":"10.1016\/j.vaccine.2009.01.094_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.094_bib20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am J Public Health"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.01.094_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nm0204-112b","article-title":"US soldiers refuse to fall in line with anthrax vaccination scheme","volume":"10","author":"Ready","year":"2004","journal-title":"Nat Med"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2009.01.094_bib22","first-page":"217","article-title":"Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios","volume":"20","author":"Geier","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2009.01.094_bib23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(02)00723-5","article-title":"Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, US Armed Forces, 1998\u20132000","volume":"21","author":"Lange","year":"2003","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.01.094_bib24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/IAI.73.2.828-833.2005","article-title":"CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine","volume":"73","author":"Xie","year":"2005","journal-title":"Infect Immun"},{"issue":"October (12\u201313)","key":"10.1016\/j.vaccine.2009.01.094_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.micinf.2007.08.002","article-title":"Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax","volume":"9","author":"Klinman","year":"2007","journal-title":"Microb Infect"},{"issue":"October","key":"10.1016\/j.vaccine.2009.01.094_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1196\/annals.1348.030","article-title":"CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine","volume":"1082","author":"Klinman","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2009.01.094_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.094_bib28","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNg","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.01.094_bib29","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","article-title":"Cutting edge: role of toll-like receptor 9 in CpG DNA-induced activation of human cells","volume":"167","author":"Takeshita","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.094_bib30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.094_bib31","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","article-title":"Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA","volume":"157","author":"Ballas","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.094_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/cimm.1996.0009","article-title":"Bacterial DNA induces murine interferon-gamma production by stimulation of IL-12 and tumor necrosis factor-alpha","volume":"167","author":"Halpern","year":"1996","journal-title":"Cell Immunol"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2009.01.094_bib33","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax","volume":"103","author":"Vietri","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.01.094_bib34","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/AAC.47.6.1968-1971.2003","article-title":"In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria","volume":"47","author":"Goldstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.01.094_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diagmicrobio.2003.09.004","article-title":"Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates","volume":"48","author":"Streit","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.01.094_bib36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.48.3.940-945.2004","article-title":"Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers","volume":"48","author":"Leighton","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"July (11\u201312)","key":"10.1016\/j.vaccine.2009.01.094_bib37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.01.094_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.58.2.303-308.1990","article-title":"Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen","volume":"58","author":"Ivins","year":"1990","journal-title":"Infect Immun"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.01.094_bib39","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1128\/IAI.73.7.4420-4422.2005","article-title":"Complement depletion renders C57BL\/6 mice sensitive to the Bacillus anthracis Sterne strain","volume":"73","author":"Harvill","year":"2005","journal-title":"Infect Immun"},{"issue":"July (21\u201322)","key":"10.1016\/j.vaccine.2009.01.094_bib40","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume":"22","author":"Klinman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.094_bib41","unstructured":"Rynkiewicz D, Rathkopf M, Ransom J, et al. Marked enhancement of antibody response to anthrax vaccine adsorbed with CpG 7909 in healthy volunteers. ICAAC abstract LB-25, 2005."},{"key":"10.1016\/j.vaccine.2009.01.094_bib42","series-title":"45th Interscience Conference on Antimicrobial agents","article-title":"In vitro and in vivo activity of dalbavancin against Bacillus anthracis","author":"Heine","year":"2005"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.01.094_bib43","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.181.8.5785","article-title":"Effect of CpG oligonucleotides on vaccine-induced B cell memory","volume":"181","author":"Tross","year":"2008","journal-title":"J Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.01.094_bib44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2672.2006.03112.x","article-title":"Past, imminent and future human medical countermeasures for anthrax","volume":"101","author":"Baillie","year":"2006","journal-title":"J Appl Microbiol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.01.094_bib45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.094_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-8518-5-11","article-title":"Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant","volume":"5","author":"Kelly","year":"2007","journal-title":"J Immune Based Ther Vaccines"},{"issue":"October 10","key":"10.1016\/j.vaccine.2009.01.094_bib47","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1128\/IAI.00712-06","article-title":"Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity","volume":"74","author":"Vitale","year":"2006","journal-title":"Infect Immun"},{"issue":"July (31\u201332)","key":"10.1016\/j.vaccine.2009.01.094_bib48","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.vaccine.2006.04.065","article-title":"Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization","volume":"24","author":"Herrmann","year":"2006","journal-title":"Vaccine"},{"issue":"May (3\u20134)","key":"10.1016\/j.vaccine.2009.01.094_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08830180600743057","article-title":"Adjuvant activity of CpG oligodeoxynucleotides","volume":"25","author":"Klinman","year":"2006","journal-title":"Int Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.094_bib50","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8","article-title":"Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells","volume":"28","author":"Sparwasser","year":"1998","journal-title":"Eur J Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.01.094_bib51","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/1521-4141(200209)32:9<2617::AID-IMMU2617>3.0.CO;2-F","article-title":"CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells","volume":"32","author":"Gursel","year":"2002","journal-title":"Eur J Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.01.094_bib52","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/IAI.01875-06","article-title":"Murine aerosol challenge model of anthrax","volume":"75","author":"Loving","year":"2007","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T20:56:24Z","timestamp":1684875384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001571"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.094","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}